On Invalid Date, Endra Life Sciences (NASDAQ: NDRA) reported Q4 2023 earnings per share (EPS) of -$0.05, up 95.15% year over year. Total Endra Life Sciences earnings for the quarter were -$1.46 million. In the same quarter last year, Endra Life Sciences's earnings per share (EPS) was -$1.03.
As of Q1 2024, Endra Life Sciences's earnings has grown year over year. Endra Life Sciences's earnings in the past year totalled -$10.06 million.
What is NDRA's earnings date?
Endra Life Sciences's earnings date is Invalid Date. Add NDRA to your watchlist to be reminded of NDRA's next earnings announcement.
What was NDRA's revenue last quarter?
On Invalid Date, Endra Life Sciences (NASDAQ: NDRA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Endra Life Sciences's revenue was $0.00.
What was NDRA's revenue growth in the past year?
As of Q1 2024, Endra Life Sciences's revenue has grown null year over year. Endra Life Sciences's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.